SFS
EIGR

Sowell Financial Services’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Sowell Financial Services’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3
Closed -$1K – 2920
2021
Q1 		$1K Hold
3
– – ﹤0.01% 3042
2020
Q4 		$1K Hold
3
– – ﹤0.01% 2649
2020
Q3 		$1K Buy
+3
New +$933 ﹤0.01% 2462

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sowell Financial Services's EIGR Position: Q2 2021 in Review

Sowell Financial Services sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q2 2021, closing a stake of 3 shares — an estimated $1K sold.

Sowell Financial Services first reported a position in EIGR in Q3 2020 and held it in 3 quarters. The position peaked at $1K in Q1 2021. 90 funds tracked by Wall St. Rank hold EIGR as of Q2 2021.

  • Sowell Financial Services reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 3 Eiger BioPharmaceuticals, Inc. shares in Q2 2021, an estimated $1K.
  • Sowell Financial Services first reported a position in Eiger BioPharmaceuticals, Inc. in Q3 2020 and held it in 3 quarters.
  • Sowell Financial Services's Eiger BioPharmaceuticals, Inc. position peaked at $1K in Q1 2021.
  • 90 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.